Blocking the excitotoxicity induced by the interaction between tPA with NMDA receptors: an antibody-based therapy in multiple sclerosis

被引：0
|
作者：
Macrez, R. [1 ]
Montagne, A. [1 ]
Gauberti, M. [1 ]
Toutirais, O. [1 ]
Le Mauff, B. [1 ]
Vivien, D. [1 ]
Docagne, F. [1 ]
Defer, G. [1 ]
机构：
[1] INSERM, U919, Caen, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P180
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 42 条
  • [21] Multiple alternative splicing of HER2 transcripts and exon skipping with potential consequences on function and antibody-based therapy
    Albitar, Maher
    Zhang, Hong
    Charifa, Ahmad
    Ip, Andrew
    Agersborg, Sally
    Mohtashamian, Arash
    Mary, Deena
    Graham, Atieh
    McNamara, Donna M.
    Waintraub, Stanley E.
    Gutierrez, Martin
    Pecora, Andrew L.
    Goy, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
    Yaccoby, Shmuel
    Ling, Wen
    Zhan, Fenghuang
    Walker, Ronald
    Barlogie, Bart
    Shaughnessy, John D., Jr.
    BLOOD, 2007, 109 (05) : 2106 - 2111
  • [23] Comparison between stem cell therapy and stem cell derived exosomes on induced multiple sclerosis in dogs
    Ahmed N. Abdallah
    Ashraf A. Shamaa
    Omar S. El-Tookhy
    Mohamed M. Bahr
    BMC Veterinary Research, 20
  • [24] Comparison between stem cell therapy and stem cell derived exosomes on induced multiple sclerosis in dogs
    Abdallah, Ahmed N.
    Shamaa, Ashraf A.
    El-Tookhy, Omar S.
    Bahr, Mohamed M.
    BMC VETERINARY RESEARCH, 2024, 20 (01)
  • [25] COMPARISON BETWEEN ANTIBODY-INDUCED MODULATION OF SUPPRESSOR CELLS AND SUPPRESSOR-CELL CHANGES IN MULTIPLE-SCLEROSIS
    ANTEL, JP
    OGER, JJF
    ARNASON, BGW
    TRANSACTIONS OF THE AMERICAN NEUROLOGICAL ASSOCIATION, 1981, 106 : 233 - 236
  • [26] DIFFERENCES BETWEEN ANTIBODY-INDUCED MODULATION OF SUPPRESSOR CELLS AND SUPPRESSOR-CELL CHANGES IN MULTIPLE-SCLEROSIS
    ANTEL, J
    OGER, J
    ARNASON, BGW
    ANNALS OF NEUROLOGY, 1981, 10 (01) : 92 - 93
  • [27] Antibody blocking of CLEC12A delays the course and attenuates EAE severity by impairing myeloid cell CNS infiltration: A potential new therapy for multiple sclerosis
    Sagan, Divya
    Singh, Narendra
    Huang, Xiaofang
    Ginwala, Rashida
    Philip, Ramila
    Nagarkatti, Mitzi
    Nagarkatti, Prakash
    Khan, Zafar
    Jain, Pooja
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [28] Antibody blocking of CLEC12A delays the course and attenuates EAE severity by impairing myeloid cell CNS infiltration: A potential new therapy for multiple sclerosis
    Sagar, D.
    Singh, N. P.
    Huang, X.
    Ginwala, R.
    Philip, R.
    Nagarkatti, M.
    Nagarkatti, P.
    Khan, Z. K.
    Jain, P.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2015, 10 : S98 - S98
  • [29] Antibody blocking of CLEC12A delays the course and attenuates EAE severity by impairing myeloid cell CNS infiltration: A potential new therapy for multiple sclerosis
    Sagar, D.
    Singh, N. P.
    Huang, X.
    Ginwala, R.
    Philip, R.
    Nagarkatti, M.
    Nagarkatti, P.
    Khan, Z. K.
    Jain, P.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2015, 10 : S98 - S99
  • [30] Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices
    Sanz, L
    Kristensen, P
    Blanco, B
    Facteau, S
    Russell, SJ
    Winter, G
    Alvarez-Vallina, L
    GENE THERAPY, 2002, 9 (15) : 1049 - 1053
12345